Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Three and six months ended June 30, 2025
Filing Date: July 3, 2025
This filing serves as a conduit for a press release (Exhibit 99.1) announcing preliminary financial results for the specified periods. The document incorporates the press release by reference into the Company's active Registration Statements on Form F-3 and Form S-8.
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain specific financial data points. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Source data does not provide clear values for financial metrics in this specific document.
Material Changes
No material changes or comparative financial data are detailed in the provided text. The filing indicates that preliminary results for the three and six months ended June 30, 2025, have been issued, but the specific variances versus prior periods are not disclosed in this excerpt.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These elements are presumed to be within the attached press release (Exhibit 99.1) but are absent from the current input.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 3, 2025) for actual revenue, net loss, and cash position figures.
- Verify the specific year-over-year and quarter-over-quarter changes in operating expenses and R&D spend.
- Confirm the Company's cash runway and any updates to capital raise plans mentioned in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones that may impact future revenue projections.